![Tero-Pekka Alastalo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Tero-Pekka Alastalo is the founder of Blueprint Genetics Oy, founded in 2008, serving as Executive Medical Director since 2020.
Dr. Alastalo is the founder of Avenue Biosciences Oy, founded in 2023, serving as Chief Executive Officer since 2023.
Former job includes President & Chief Medical Officer, GM-US Operation at Precordior Oy from 2022 to 2024.
Postes actifs de Tero-Pekka Alastalo
| Sociétés | Poste | Début |
|---|---|---|
Blueprint Genetics Oy
 Blueprint Genetics Oy BiotechnologyHealth Technology Provides genetic diagnostics and clinical interpretation of hereditary diseases | Directeur Technique/Scientifique/R&D | 01/01/2008 |
Anciens postes connus de Tero-Pekka Alastalo
| Sociétés | Poste | Fin |
|---|---|---|
Precordior Oy
 Precordior Oy Information Technology ServicesTechnology Services Provides health tracking technology services | President | 01/08/2024 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
7
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Blueprint Genetics Oy
Blueprint Genetics Oy BiotechnologyHealth Technology Provides genetic diagnostics and clinical interpretation of hereditary diseases | Health Technology |
Precordior Oy
Precordior Oy Information Technology ServicesTechnology Services Provides health tracking technology services | Technology Services |
